Sveriges mest populära poddar
Research To Practice | Oncology Videos
Hälsa och motionMedicin

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)

31 min•9 april 2025

Featuring a slide presentation and related discussion from Dr Justin F Gainor, including the following topics:

  • Duration of responses observed with ALK inhibitors in patients with ALK-positive metastatic non-small cell lung cancer (mNSCLC) (0:00)
  • Current role of other systemic therapy options for the treatment of ALK-positive mNSCLC; management of oligometastatic disease (8:38)
  • Local therapy approaches for treating CNS disease in ALK-positive mNSCLC (18:32)
  • Tolerability profile of lorlatinib (23:28)
  • Review of clinical investigator survey results (37:08)
  • Novel ALK inhibitors under clinical development (53:31)

CME information and select publications

Fler avsnitt av Research To Practice | Oncology Videos

Visa alla avsnitt av Research To Practice | Oncology Videos
Oral SERDs for Breast Cancer | Erica Mayer, MD, MPH, FASCO
•29 min
Oral SERDs for Breast Cancer | Aditya Bardia, MD, MPH
•28 min
EGFR-Mutant Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances
•57 min
EGFR-Mutant Non-Small Cell Lung Cancer | Suresh S Ramalingam, MD
•26 min
EGFR-Mutant Non-Small Cell Lung Cancer | Helena Yu, MD
•30 min
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
•17 min
Prostate Cancer — Year in Review Series on Relevant New Datasets and Advances
•58 min
Prostate Cancer | Scott T Tagawa, MD, MS
•25 min
Prostate Cancer | Andrew J Armstrong, MD, ScM
•24 min
Menin Inhibitors in Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
•59 min

Research To Practice | Oncology Videos med Dr Neil Love finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.